Decentralized Clinical Trials and Patient Needs

By ,

Published on: Apr 30, 2020

Return to Insights Center

Related Insights

Blog

Including patients in DCT design

Sep 13, 2022

Blog

A patient-centric approach to managing clinical trial complexity

Jul 13, 2021

Report

New Medicines, Novel Insights: Advancing rare disease drug development

May 22, 2023

Report

New Medicines, Novel Insights: Accelerating development of cell and gene therapies

May 22, 2023

Article

Australia: Infrastructure and Innovations for Clinical Trials

Aug 28, 2023

Report

New Medicines, Novel Insights: Achieving patient-guided drug development

Oct 30, 2023

Blog

Adapting the validation process for PROs for rare diseases and other diseases with large unmet need and/or rapid progression

Apr 23, 2024

Video

Part 2: Risk-based Quality Management Video (RBQM) Series

Nov 11, 2021

Blog

Decentralized Trials: Considerations for Building a New Patient-Centric Model

May 13, 2021

Article

Decentralized clinical trials - A more patient-centric approach

May 10, 2021

Article

4 Insights on decentralized trials for biotechs

Jul 1, 2021

Blog

Taking a Proactive Approach to Post-Launch Patient Accessibility in Strategic Planning

Aug 4, 2022

Related Insights

Blog

Including patients in DCT design

Sep 13, 2022

Blog

A patient-centric approach to managing clinical trial complexity

Jul 13, 2021

Report

New Medicines, Novel Insights: Advancing rare disease drug development

May 22, 2023

Report

New Medicines, Novel Insights: Accelerating development of cell and gene therapies

May 22, 2023

Article

Australia: Infrastructure and Innovations for Clinical Trials

Aug 28, 2023

Report

New Medicines, Novel Insights: Achieving patient-guided drug development

Oct 30, 2023

Show more